Merck CEO Rob Davis joins Bloomberg's Jonathan Ferro and Lisa Abramowicz to discuss the approval of the company's treatment for high blood pressure called Winrevair.

Former SEC Chair Gary Gensler Talks Revival of US Equity Market
15:09

Gotham FC Governor Carolyn Tisch-Blodgett Talks Growth in NY Soccer
08:18

Nasdaq President Nelson Griggs Talks SK Hynix Public Listing
06:14